During the past decade, Klinikum Nurnberg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Nurnberg" #1 collaborator was "AGO Breast Study Group e.V." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Nurnberg" are "Unspecified Adult Solid Tumor, Protocol Specific" (6 trials), "Lung Cancer" (2 trials), "Testicular Germ Cell Tumor" (2 trials), "Acute Heart Failure" (1 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Nurnberg" in a lesser frequency.

Most popular intervention types in "Klinikum Nurnberg" are "Drug" (12 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "sabarubicin" (2 trials), "BIBX 1382" (1 trials), "FOLFIRI regimen" (1 trials), "Goal-directed preload and afterload decrement" (1 trials) and "ISIS 3521" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Nurnberg" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Nurnberg". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Klinikum Nurnberg, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Nurnberg, 6 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".